Zeus Medical (PRIVATE.ZEUSMED)

Overall impact
C (48)

Commentary

Zeus Medical is an average overall performer. With a 'C' rating of 47.9 for overall impact (37th percentile compared to all companies), Zeus Medical ranks 174th out of 192 industry peers, behind ConTIPI, Restoration Robotics, Corindus Vascular Robotics and 170 others, and ahead of MLase, Idexx Laboratories, Ergotron and 15 others. On top material causes for Zeus Medical's industry (Health Care Equipment & Supplies), Zeus Medical performs well in Technology Innovation (89.4 score), Child and Maternal Health (95.1), Child and Maternal Health (95.1) and 6 other causes where it received an 'A' score and performs poorly in Reduced Inequality (19.1 score), Sanitation Access (26.0), Decent, Safe Work Opportunities (33.8) and 28 other causes where it received a 'D' or 'F' score.
Screens
Fur
Impact
Cause PRIVATE.ZEUSMED
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
2,400
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
South Carolina, United States
Share classes
PRIVATE.ZEUSMED
Description
Manufacturer of polymer extrusion products intended for medical devices and select industrial applications. The company specializes in the design, development and extrusion of fluoropolymer tubing, biomaterials, coated optical fiber, heat-shrinkable tubing and insulated wire along with monofilament and drawn fiber, enabling its clients to deliver invasive interventional procedures to drive significantly improved health outcomes.
Material causes
Ethos considers the following causes material for Zeus Medical, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.